Related content

miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor

By Guo Jinling   Xia Bairong   Meng Fanling   Lou Ge  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1557-1564

Springer Publishing Company

Access to resources Recommend Favorite

Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy)

By Lukanova A.  

Cancer Causes and Control, Vol. 14, Iss. 3, 2003-04 ,pp. : 285-292

Springer Publishing Company

Access to resources Recommend Favorite

Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients

By Tarnowski B.  

Breast Cancer Research and Treatment, Vol. 88, Iss. 3, 2004-12 ,pp. : 287-288

Springer Publishing Company

Access to resources Recommend Favorite

The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: Biology and therapeutic relevance

By Gross J.M.  

Cancer and Metastasis Reviews, Vol. 22, Iss. 4, 2003-12 ,pp. : 327-336

Springer Publishing Company

Access to resources Recommend Favorite

Silencing insulinlike growth factor1 receptor expression inhibits gastric cancer cell proliferation and invasion

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 633-638

Spandidos Publications

Access to resources Recommend Favorite